PETROSCRAP.COM

Silence Therapeutics to Present at Upcoming Investor Conferences
Silence Therapeutics plc announces that Philip Haworth, Ph.D., chief executive officer, will present corporate updates at two upcoming industry and financial conferences. Â Dr. Haworth’s presentations will focus on Silence Therapeutics’ comprehensive RNA interference therapeutics platform, broad clinical-stage pipeline and multiple ongoing collaborations with leading pharmaceutical companies.

Read more on PR Newswire via Yahoo! Finance

This entry was posted on Wednesday, May 12th, 2010 at 5:36 am and is filed under Polymer News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.